<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>The Kinder Side of a Scorpion Sting</title>
    <meta content="11SCOR" name="slug"/>
    <meta content="11" name="publication_day_of_month"/>
    <meta content="7" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Tuesday" name="publication_day_of_week"/>
    <meta content="Health &amp; Fitness" name="dsk"/>
    <meta content="8" name="print_page_number"/>
    <meta content="F" name="print_section"/>
    <meta content="5" name="print_column"/>
    <meta content="Health" name="online_sections"/>
    <docdata>
      <doc-id id-string="1214000"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <series series.name="VITAL SIGNS: RISKS AND REMEDIES"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Scorpions</classifier>
        <classifier class="indexing_service" type="descriptor">Transplants</classifier>
        <classifier class="indexing_service" type="descriptor">Immune System</classifier>
        <classifier class="indexing_service" type="descriptor">Surgery and Surgeons</classifier>
        <classifier class="indexing_service" type="descriptor">Lupus Erythematosus</classifier>
        <classifier class="indexing_service" type="descriptor">Arthritis and Rheumatism</classifier>
        <org class="indexing_service">University of California (Irvine)</org>
        <person class="indexing_service">Nagourney, Eric</person>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Columns/Vital Signs</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Transplants</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Healthcare</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Doctors</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Surgery and Surgeons</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Pharmaceutical, Biotechnology and Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Arthritis and Rheumatism</classifier>
        <classifier class="online_producer" type="general_descriptor">Immune System</classifier>
        <classifier class="online_producer" type="general_descriptor">Transplants</classifier>
        <classifier class="online_producer" type="general_descriptor">Surgery and Surgeons</classifier>
        <classifier class="online_producer" type="general_descriptor">Arthritis and Rheumatism</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Insects</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000711T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9B01EFDB1738F932A25754C0A9669C8B63" item-length="275" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>The Kinder Side of a Scorpion Sting</hl1>
      </hedline>
      <byline class="print_byline">By ERIC NAGOURNEY</byline>
      <byline class="normalized_byline">Nagourney, Eric</byline>
      <abstract>
        <p>Researchers at University of California at Irvine develop a chemical that works like scorpion venom, and they say it may one day help doctors who perform organ transplants or treat autoimmune diseases like lupus and arthritis; photo (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>The only things scorpions inspire in most people are fear and a desire to get out of the way of their poison-tipped stingers.</p>
        <p>But researchers at the University of California at Irvine say they have developed a chemical that works like scorpion venom, but instead of harming people, it may one day help doctors who perform organ transplants or treat autoimmune diseases like lupus and arthritis.</p>
      </block>
      <block class="full_text">
        <p>The only things scorpions inspire in most people are fear and a desire to get out of the way of their poison-tipped stingers.</p>
        <p>But researchers at the University of California at Irvine say they have developed a chemical that works like scorpion venom, but instead of harming people, it may one day help doctors who perform organ transplants or treat autoimmune diseases like lupus and arthritis.</p>
        <p>The findings were reported last week in The Proceedings of the National Academy of Sciences.</p>
        <p>The author of the study, Dr. Heike Wulff, a pharmaceutical chemist, said in an interview that the synthetic chemical, TRAM-34, had not been modeled on scorpion venom, but was inspired by discoveries about how the poison affected the cells of scorpion victims.</p>
        <p>The venom inactivates some cell functions, including the immune response system, but is not usually fatal.</p>
        <p>Likewise, the drugs, like cyclosporin, now given to suppress the immune response in transplant and other patients also have detrimental effects, like gastrointestinal and urinary tract problems.</p>
        <p>TRAM-34 appears to be more adept at suppressing T-cells, part of the body's arsenal against foreign objects, without hurting the production of enzymes and other important cellular functions.</p>
        <p>Dr. Wulff said the findings were preliminary, and he could not predict when the chemical might be tested on people.</p>
        <p>VITAL SIGNS: RISKS AND REMEDIES</p>
      </block>
    </body.content>
  </body>
</nitf>
